Artwork

Nội dung được cung cấp bởi Sheree Dibiase. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Sheree Dibiase hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.
Player FM - Ứng dụng Podcast
Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !

Revolutionizing Women's Health: Non-Drug Therapy for Yeast and Bacterial Vaginosis | Innovative Microbiocidal Light Device | Potential for Telemedicine Integration | Addressing Unmet Needs | Gregg Klang

53:02
 
Chia sẻ
 

Manage episode 433921217 series 3521691
Nội dung được cung cấp bởi Sheree Dibiase. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Sheree Dibiase hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

Gregg Klang, Femtech founder of CERN Corporation, discusses the development of a microbiocidal light device for yeast and bacterial vaginosis treatment. The device offers an alternative to drug-based therapies, catering to those who prefer non-medication options. Greg explains the status of development, including human trials, in vitro and ex vivo testing, and animal testing for safety. Tune in to learn more about his journey into women's health tech innovation with CERN Corporation.

Timestamps

  • (01:20) CERN Corporation was founded to develop a non-drug therapy for yeast and bacterial vaginosis, targeting those for whom drug-based therapies are not effective or desired.
  • (10:23) The CERN device uses microbiocidal light therapy to target key pathogens associated with yeast and bacterial vaginosis, providing a non-drug treatment option.
  • (16:39) The CERN device is designed to accommodate different sizes to ensure comfort and effectiveness for women with varying pelvic floor conditions, including hypertonicity.
  • (32:26) Physicians are impressed by the CERN device's approach and potential benefits for patients, expressing interest in its availability and integration into their practices.
  • (44:24) The founder of CERN Corporation emphasizes the importance of the team's support and expertise in driving the development and success of the non-drug therapy device.

Host Bio

This podcast is hosted by Sheree Dibiase, PT ICLM. She is a nationally recognized women's health physical therapist who owns seven private clinics — one of the biggest networks in the US. She has spent 30+ years practicing in the oncology, pelvic floor, and prenatal postpartum healthcare spaces. She was also a professor for seven years a Loma Linda University where she taught kinesiology.

Brought to you by...

https://lakecitypt.com/ - Women's health physical therapy.

https://pelvicfloorpro.com/ - Pelvic floor physical therapy from home.

Keywords

Femtech, Women's Health, Pelvic Floor, Breast Cancer, Prenatal & postpartum

  continue reading

34 tập

Artwork
iconChia sẻ
 
Manage episode 433921217 series 3521691
Nội dung được cung cấp bởi Sheree Dibiase. Tất cả nội dung podcast bao gồm các tập, đồ họa và mô tả podcast đều được Sheree Dibiase hoặc đối tác nền tảng podcast của họ tải lên và cung cấp trực tiếp. Nếu bạn cho rằng ai đó đang sử dụng tác phẩm có bản quyền của bạn mà không có sự cho phép của bạn, bạn có thể làm theo quy trình được nêu ở đây https://vi.player.fm/legal.

Gregg Klang, Femtech founder of CERN Corporation, discusses the development of a microbiocidal light device for yeast and bacterial vaginosis treatment. The device offers an alternative to drug-based therapies, catering to those who prefer non-medication options. Greg explains the status of development, including human trials, in vitro and ex vivo testing, and animal testing for safety. Tune in to learn more about his journey into women's health tech innovation with CERN Corporation.

Timestamps

  • (01:20) CERN Corporation was founded to develop a non-drug therapy for yeast and bacterial vaginosis, targeting those for whom drug-based therapies are not effective or desired.
  • (10:23) The CERN device uses microbiocidal light therapy to target key pathogens associated with yeast and bacterial vaginosis, providing a non-drug treatment option.
  • (16:39) The CERN device is designed to accommodate different sizes to ensure comfort and effectiveness for women with varying pelvic floor conditions, including hypertonicity.
  • (32:26) Physicians are impressed by the CERN device's approach and potential benefits for patients, expressing interest in its availability and integration into their practices.
  • (44:24) The founder of CERN Corporation emphasizes the importance of the team's support and expertise in driving the development and success of the non-drug therapy device.

Host Bio

This podcast is hosted by Sheree Dibiase, PT ICLM. She is a nationally recognized women's health physical therapist who owns seven private clinics — one of the biggest networks in the US. She has spent 30+ years practicing in the oncology, pelvic floor, and prenatal postpartum healthcare spaces. She was also a professor for seven years a Loma Linda University where she taught kinesiology.

Brought to you by...

https://lakecitypt.com/ - Women's health physical therapy.

https://pelvicfloorpro.com/ - Pelvic floor physical therapy from home.

Keywords

Femtech, Women's Health, Pelvic Floor, Breast Cancer, Prenatal & postpartum

  continue reading

34 tập

ทุกตอน

×
 
Loading …

Chào mừng bạn đến với Player FM!

Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.

 

Hướng dẫn sử dụng nhanh